Boron tribromide → HCID 135931642, compound
Reaction equation
C[O:2][C:3]1[CH:8]=[CH:7][C:6]([C:9]2[N:13]3[CH:14]=[CH:15][N:16]=[C:17]([NH:18][CH2:19][C:20]4[CH:25]=[CH:24][C:23]([S:26]([NH2:29])(=[O:28])=[O:27])=[CH:22][CH:21]=4)[C:12]3=[N:11][CH:10]=2)=[CH:5][C:4]=1[CH3:30].B(Br)(Br)Br>ClCCl>[OH:2][C:3]1[CH:8]=[CH:7][C:6]([C:9]2[N:13]3[CH:14]=[CH:15][N:16]=[C:17]([NH:18][CH2:19][C:20]4[CH:21]=[CH:22][C:23]([S:26]([NH2:29])(=[O:28])=[O:27])=[CH:24][CH:25]=4)[C:12]3=[N:11][CH:10]=2)=[CH:5][C:4]=1[CH3:30]Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of 4-{[3-(4-Methoxy-3-methyl-phenyl)-imidazo[1,2-a]pyrazin-8-ylamino]-methyl}-benzenesulfonamide (0.167 g, 0.39 mmol) in dichloromethane (5 mL) at −78° C. was added boron tribromide (3.9 ml, 3.9 mmol, 1 M solution in dichloromethane). The reaction was allowed to warm gradually to ambient temperature then quenched with saturated aqueous sodium bicarbonate solution (30 mL). The reaction mixture was extracted with ethyl acetate (3×30 ml), the organic layers were combined and dried with magnesium sulphate, filtered and concentrated in vaccuo. The residue was taken up in DMSO and purified by prep HPLC. The product, 4-{[3-(4-Hydroxy-3-methyl-phenyl)-imidazo[1,2-a]pyrazin-8-ylamino]-methyl}-benzenesulfonamide, is obtained as a white solid (25 mg, 16%) (LC-MS m/z 410 [M+H]+).
Workup
- customthen quenched with saturated aqueous sodium bicarbonate solution (30 mL)
- extractionThe reaction mixture was extracted with ethyl acetate (3×30 ml)
- dry with materialdried with magnesium sulphate
- filtrationfiltered
- concentrationconcentrated in vaccuo
- custompurified by prep HPLC
Sources & evidence
- ORD record
- ord-792a59f5fe6f4cbd8a107acb15c4759c
- Source dataset
- uspto-grants-2013_01
- Patent number
- US08362018B2
Reaction notes
Loading…